Filing Details
- Accession Number:
- 0000950170-24-052390
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-02 19:00:11
- Reporting Period:
- 2024-04-30
- Accepted Time:
- 2024-05-02 19:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1306119 | T Kevin Conroy | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-30 | 2,489 | $0.00 | 1,156,638 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-04-30 | 708 | $30.02 | 1,157,346 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2024-05-01 | 1,155 | $60.15 | 1,156,191 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 28,043 | Indirect | Held in 401(k) Plan |
| Common Stock | 73,280 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 72,067 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 21,730 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 21,730 | Indirect | Held in Grantor Retained Annuity Trust |
| Common Stock | 21,729 | Indirect | Held in Grantor Retained Annuity Trust |
Footnotes
- Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
- In addition to the shares of Common Stock reported on this Form 4, which total 1,394,770 shares, Mr. Conroy also holds, in the aggregate, an additional 683,018 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- Represents shares of common stock purchased through Employee Stock Purchase Plan.
- Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
Billionaire Hedge Funds
